Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology - Egypt
doi 10.1155/2018/8543763
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Molecular Pathogenesis of Hepatocellular Carcinoma

2010English

Liver Transplantation Recipients With Nonalcoholic Steatohepatitis Have Lower Risk Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

A Case Report of a Rare Hepatocellular Carcinoma Derived From Nonalcoholic Steatohepatitis

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2009English

Molecular Pathogenesis of NASH

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

A New Method to Induce Nonalcoholic Steatohepatitis (NASH) in Mice

BMC Gastroenterology
MedicineGastroenterology
2019English

Mouse Models of Nonalcoholic Steatohepatitis Towards Optimization of Their Relevance to Human NASH

Hepatology
MedicineHepatology
2019English

The Roles of Epigenetic Regulators and Inflammasome in Hepatocellular Carcinoma Tumorigenesis in Patients With Alcoholic Steatohepatitis (ASH) vs Non-Alcoholic Steatohepatitis (NASH)

Clinical Oncology and Research
2019English

Letter: Clinical Response to Pioglitazone in Nonalcoholic Steatohepatitis [NASH] Treatment-Use of Pharmacokinetic Surrogate

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy